Faculté des Sciences pharmaceutiques et biologiques, LUNAM Université, Université de Nantes, Groupe Mer, Molécules, Santé-EA 2160, Institut Universitaire Mer et Littoral-FR CNRS 3473, Nantes, France.
Mar Drugs. 2013 Apr 17;11(4):1304-15. doi: 10.3390/md11041304.
The marine sponge, Axinyssa djiferi, collected on mangrove tree roots in Senegal, was investigated for glycolipids. A mixture containing new glycosphingolipids, named axidjiferoside-A, -B and -C, accounted for 0.07% of sponge biomass (dry weight) and for 2.16% of total lipids. It showed a significant antimalarial activity, with a 50% inhibitory concentration (IC50) of 0.53 ± 0.2 μM against a chloroquine-resistant strain of Plasmodium falciparum. They were identified as homologous β-galactopyranosylceramides composed of 2-amino-(6E)-octadec-6-en-1,3,4-triol, and the major one, axidjiferoside-A (around 60%), contained 2-hydroxytetracosanoic acid. Cytotoxicity was studied in vitro on human cancer cell lines (multiple myeloma, colorectal adenocarcinoma, glioblastoma and two lung cancer NSCLC-N6 and A549). Results of this investigation showed that axidjiferosides are of interest, because they proved a good antiplasmodial activity, with only a low cytotoxicity against various human cell lines and no significant antitrypanosomal and antileishmanial activity. Thus, it seems that galactosylceramides with a β anomeric configuration may be suitable in searching for new antimalarial drugs.
从塞内加尔红树林根部采集的海洋海绵 Axinyssa djiferi 被用于研究糖脂。该混合物含有新的糖鞘脂,分别命名为 axidjiferoside-A、-B 和 -C,占海绵生物量(干重)的 0.07%,占总脂质的 2.16%。它表现出显著的抗疟活性,对氯喹耐药株恶性疟原虫的 50%抑制浓度(IC50)为 0.53±0.2μM。它们被鉴定为同源的β-半乳糖吡喃基神经酰胺,由 2-氨基-(6E)-十八-6-烯-1,3,4-三醇组成,主要成分 axidjiferoside-A(约 60%)含有 2-羟基二十四烷酸。体外研究了对人癌细胞系(多发性骨髓瘤、结直肠腺癌、神经胶质瘤和两种肺癌 NSCLC-N6 和 A549)的细胞毒性。该研究的结果表明,axidjiferosides 具有一定的研究价值,因为它们表现出良好的抗疟活性,对各种人癌细胞系的细胞毒性较低,且对锥虫和利什曼原虫没有显著的抗活性。因此,β构型的半乳糖神经酰胺可能适合用于寻找新的抗疟药物。